Annual Current Liabilities
$60.57 M
+$17.77 M+41.53%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual total current liabilities is $60.57 million, with the most recent change of +$17.77 million (+41.53%) on December 31, 2022.
- During the last 3 years, ORTX annual current liabilities has risen by +$4.71 million (+8.43%).
Performance
ORTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$49.38 M
-$8.14 M-14.16%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly total current liabilities is $49.38 million, with the most recent change of -$8.14 million (-14.16%) on September 30, 2023.
- Over the past year, ORTX quarterly current liabilities has dropped by -$890.00 thousand (-1.77%).
Performance
ORTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ORTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.5% | -1.8% |
| 3 y3 years | +8.4% | +21.1% |
| 5 y5 years | +463.1% | - |
ORTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -29.3% | -18.5% | -13.3% |
| 5 y | 5-year | at high | -29.3% | -18.5% | -17.4% |
| alltime | all time | at high | -93.7% | -18.5% | -78.2% |
Orchard Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $49.38 M(-14.2%) |
| Jun 2023 | - | $57.52 M(+7.9%) |
| Mar 2023 | - | $53.29 M(-12.0%) |
| Dec 2022 | $60.57 M(+41.5%) | $60.57 M(+20.5%) |
| Sep 2022 | - | $50.27 M(+3.8%) |
| Jun 2022 | - | $48.41 M(+3.2%) |
| Mar 2022 | - | $46.91 M(+9.6%) |
| Dec 2021 | $42.79 M(-17.0%) | $42.79 M(-3.3%) |
| Sep 2021 | - | $44.24 M(+8.0%) |
| Jun 2021 | - | $40.95 M(-15.5%) |
| Mar 2021 | - | $48.48 M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $51.56 M(-7.7%) | $51.56 M(+26.5%) |
| Sep 2020 | - | $40.76 M(-3.0%) |
| Jun 2020 | - | $42.02 M(-6.2%) |
| Mar 2020 | - | $44.80 M(-19.8%) |
| Dec 2019 | $55.86 M(+16.6%) | $55.86 M(+26.1%) |
| Sep 2019 | - | $44.31 M(-20.1%) |
| Jun 2019 | - | $55.44 M(+59.8%) |
| Mar 2019 | - | $34.70 M(-27.6%) |
| Dec 2018 | $47.91 M(+345.4%) | $47.91 M(+13.3%) |
| Jun 2018 | - | $42.28 M(+293.1%) |
| Dec 2017 | $10.76 M(+181.9%) | $10.76 M |
| Dec 2016 | $3.81 M | - |
FAQ
- What is Orchard Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Orchard Therapeutics?
- What is Orchard Therapeutics annual current liabilities year-on-year change?
- What is Orchard Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly current liabilities year-on-year change?
What is Orchard Therapeutics annual total current liabilities?
The current annual current liabilities of ORTX is $60.57 M
What is the all time high annual current liabilities for Orchard Therapeutics?
Orchard Therapeutics all-time high annual total current liabilities is $60.57 M
What is Orchard Therapeutics annual current liabilities year-on-year change?
Over the past year, ORTX annual total current liabilities has changed by +$17.77 M (+41.53%)
What is Orchard Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ORTX is $49.38 M
What is the all time high quarterly current liabilities for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly total current liabilities is $60.57 M
What is Orchard Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ORTX quarterly total current liabilities has changed by -$890.00 K (-1.77%)